Group (n = 6) | Heart (g) | Kidney (g) | Liver (g) | Spleen (g) |
---|
NC | 0.29 ± 0.03a
| 0.55 ± 0.04a
| 3.25 ± 0.44a
| 0.42 ± 0.09a
|
P407 | 0.31 ± 0.04a
| 0.61 ± 0.08a
| 4.66 ± 0.88b
| 0.87 ± 0.17c
|
P407 + ATV | 0.29 ± 0.03a
| 0.59 ± 0.03a
| 4.37 ± 1.23ab
| 0.63 ± 0.07b
|
P407 + RBBF | 0.28 ± 0.03a
| 0.56 ± 0.02a
| 4.07 ± 0.78ab
| 0.52 ± 0.05ab
|
P407 + SBBF | 0.27 ± 0.04a
| 0.56 ± 0.03a
| 4.19 ± 0.86ab
| 0.63 ± 0.11b
|
P407 + SBF | 0.30 ± 0.02a
| 0.57 ± 0.05a
| 4.33 ± 0.84ab
| 0.72 ± 0.10b
|
- Values are means ± Standard deviations
- Values with different superscripts down the column differ significantly (p < 0.05)
-
NC Normal Control Rats, P407 Poloxamer 407 Induced Rats (500 mg/kg), P407 + ATV P407 Induced Hyperlipidemic Rats (500 mg/kg) + Atorvastatin (10 mg/kg), P407 + RBBF P407 Induced Hyperlipidemic Rats (500 mg/kg) + Root bark Biflavonoid Fraction (200 mg/kg), P407 + SBBF P407 Induced Hyperlipidemic Rats (500 mg/kg) + Stem bark Biflavonoid Fraction (200 mg/kg), P407 + SBF P407 Induced Hyperlipidemic Rats (500 mg/kg) + Seed Biflavonoid Fraction (200 mg/kg)